NEW YORK, Aug. 1, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Insulin-
Global
http://www.reportlinker.com/p0578240/Insulin–Global.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
This package contains 63 insulin market analyses from the
following countries: Austria, Belgium, Bulgaria, Czech
Republic,Denmark, Estonia, Finland, France, Germany, Greece,
Hungary, Ireland, Italy, Latvia, Lithuania, Macedonia, Moldova, the
Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia,
Slovenia, Spain, Sweden, Ukraine, the United Kingdom, Armenia,
Azerbaijan, China, Georgia, India, Indonesia, Iran, Japan, Jordan,
Kazakhstan, Kyrgyzstan, Malaysia, Oman, Pakistan, Singapore, South
Korea, Sri Lanka, Thailand, Turkey, Canada, Chile, Colombia,
Ecuador, Mexico, Panama, Peru, the United States and Uruguay.
The insulin market analyses give an overview of the actual
situation, trends and future outlook of the insulin markets in
different countries. The market analyses provide essential market
information for decision-makers including:
* Overall market value for insulin, 2004-2010
* Overall market volume for insulin, 2004-2010
* Market value and volume for insulin by type (bulk, dosage)
* Forecasts and future outlook of the market till 2016
* Country overview, macroeconomic indicators and indicators of
doing business
These market analyses answers to questions such as:
* What is the size of the insulin market in different
countries?
* How the insulin market has been developing in different
countries? How does the future look like?
* What is the potential for the insuli
‘/>”/>
SOURCE
